Study of fetomaternal outcomes in maternal jaundice at term pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20252520Keywords:
Acute fatty liver of pregnancy, Fetal outcomes, Intrahepatic cholestasis of pregnancy, Maternal jaundice, Viral hepatitisAbstract
Background: Jaundice in pregnancy, although uncommon, is associated with significant fetomaternal morbidity and mortality. Etiologies include viral hepatitis, intrahepatic cholestasis of pregnancy (ICP) and acute fatty liver of pregnancy (AFLP), each carrying unique risks.
Methods: This prospective observational study included 30 term pregnant women with jaundice (serum bilirubin ≥2.5 mg/dl), conducted at F.H. Medical College, Agra (July 2023–June 2024). Demographic, clinical and laboratory data were collected and outcomes were analyzed.
Results: Viral hepatitis was the most common etiology (50%), followed by ICP (30%) and AFLP (20%). Hepatic encephalopathy and coagulopathy were noted in 13.3% and 23.3% respectively. Cesarean delivery occurred in 40% of cases. NICU admission was needed in 33.3% and perinatal mortality was 3.3%.
Conclusions: Maternal jaundice at term is a critical condition requiring early diagnosis and multidisciplinary care. The severe outcomes associated with AFLP and viral hepatitis underscore the need for timely intervention.
Metrics
References
American College of Obstetricians and Gynecologists. Management of Hepatic Disorders in Pregnancy. Obstet Gynecol. 2020;135(5):164–77.
Herrera J, Illanes SE, Miranda S. Acute fatty liver of pregnancy: diagnosis and management. Obstet Gynecol. 2019;134(2):337–42.
Smith A, Kapoor R, Banerjee R. Viral hepatitis in pregnancy: epidemiology and outcomes. Liver Int. 2021;41(8):1817–28.
Marsden J, Kelly L, Davies H. Intrahepatic cholestasis in pregnancy: maternal and fetal outcomes. BJOG. 2018;125(1):47–54.
Gurule S, Jain S, Bhalerao A. Fetomaternal outcome in maternal jaundice at term. Int J Reprod Contracept Obstet Gynecol. 2019;8(5):2016–21. DOI: https://doi.org/10.18203/2320-1770.ijrcog20191940
Tran TT. Hepatitis B and pregnancy: screening, treatment and prevention of vertical transmission. Am J Gastroenterol. 2009;104(3):659–64.
Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067–76. DOI: https://doi.org/10.1002/hep.22130
Tan J, Surti B. Acute fatty liver of pregnancy: an update. Curr Opin Obstet Gynecol. 2018;30(2):61–6.
Riely CA. Liver disease in the pregnant patient. Am J Gastroenterol. 1999;94(8):1728–32. DOI: https://doi.org/10.1016/S0002-9270(99)00255-5
Ch’ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51(6):876–80. DOI: https://doi.org/10.1136/gut.51.6.876
Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet. 2010;375(9714):594–605. DOI: https://doi.org/10.1016/S0140-6736(09)61495-1
Rathi MS, Marwah S, Tripathi V. Maternal and perinatal outcome in jaundice during pregnancy. J Obstet Gynecol India. 2015;65(4):242–5.
de Silva TI, Brook MG, Evans HE. Acute viral hepatitis in pregnancy. Lancet Infect Dis. 2010;10(5):339–46.
Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005;294(21):2751–7. DOI: https://doi.org/10.1001/jama.294.21.2751
Shukla S, Meena R, Jain A. Jaundice in pregnancy: fetomaternal outcome in a tertiary care center. Int J Med Sci Public Health. 2018;7(10):802–5.
Downloads
Published
How to Cite
Issue
Section
